Sign inJoin waitlistJoin the waitlist

CK

Carla Kurkjian

Physician · Mercy Health Oklahoma Communities

Credentials: · · · · ·

History

Mercy Health Oklahoma Communities
Present

Hematology and Medical Oncology
University of Oklahoma College of Medicine
2004–2007
Internal Medicine
University of Oklahoma College of Medicine
2001–2004
University of Oklahoma College of Medicine
1997–2001

Research

Phase Ib study of the MEK inhibitor cobimetinib (GDC-0973) in combination with the PI3K inhibitor pictilisib (GDC-0941) in patients with advanced solid tumors
Investigational New Drugs · 2020 · 84 citations
A phase 1 study of the sachet formulation of the oral dual PI3K/mTOR inhibitor BEZ235 given twice daily (BID) in patients with advanced solid tumors
Investigational New Drugs · 2015 · 79 citations
A first-in-human phase I study of the oral Notch inhibitor, LY900009, in patients with advanced cancer
European Journal of Cancer · 2016 · 72 citations

Shubham Pant
8 papers
JI
Jeffrey Infante
7 papers
JB
Johanna Bendell
7 papers
HB
Howard Burris
6 papers
Shivaani Kummar
5 papers
Kathleen Moore
3 papers · 1 as a fellow
Mohamed Dabaja
3 papers
RK
Rammurti Kamble
3 papers
DT
Dana Thompson
2 papers
Manish Patel
2 papers
Mohamad Cherry
2 papers
CA
Carol Aghajanian
1 paper

Clinical trials

Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)
Site PI · Recruiting
Elephas
2025–2038
GEMINI-NSCLC: NSCLC Biomarker Study
Site PI · Recruiting
Tempus AI
2022–2029
Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays
Site PI · Recruiting
Tempus AI
2022–2029